IP Library Granted Patent US 8,158,575
Granted Patent B2
US 8,158,575 · App. 12/498,077 · Granted Apr 17, 2012

Agent for the prevention and treatment of sexually transmitted diseases-I

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,158,575
App. No.
12/498,077
Granted
Apr 17, 2012
Kind
B2
Abstract

Use of a polylysine, polyamidoamine or polypropylenimine dendrimer having naphthyl disulphonate terminal groups as a topically applied agent in prophylaxis or treatment of sexually transmitted diseases.

Claims (8)

1. A method for the therapeutic treatment of sexually transmitted diseases in a human patient comprising administering topically to the patient an effective amount of a compound of the Formula I:

wherein R represents a group of the Formula IV, wherein * indicates the point of attachment:

or a pharmaceutically acceptable salt thereof, and

wherein said disease is a vaginally or rectally transmitted disease selected from the group consisting of HSV-1, HSV-2, HIV-1, HIV-2, HPV and Chlamydia trachomatis infection.

2. The method according to claim 1 , wherein the pharmaceutically acceptable salt is selected from metallic salts, organic salts made from organic amines, quaternary amine salts, sulphonium salts, and phosphonium salts.

3. The method according to claim 2 , wherein said metallic salt is selected from the group consisting of aluminium, calcium, lithium, magnesium, potassium, sodium, zinc salts.

4. The method according to claim 2 , wherein said organic amine is selected from the group consisting of N,N′-dibenzylethylenediamine, chloroprocaine, diethanolamine, ethylenediamine, dicyclohexylamine, meglumine (N-methylglucamine) and procaine.

5. The method according to claim 2 , wherein said quaternary amine salt is choline.